These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30306706)

  • 1. Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy.
    Chen HL; OuYang HY; Le Y; Jiang P; Tang H; Yu ZS; He MK; Tang YQ; Shi M
    Cancer Med; 2018 Nov; 7(11):5339-5350. PubMed ID: 30306706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma.
    Ohno A; Yorita K; Haruyama Y; Kondo K; Kato A; Ohtomo T; Kawaguchi M; Marutuska K; Chijiiwa K; Kataoka H
    Liver Int; 2014 Jul; 34(6):942-52. PubMed ID: 24433439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma.
    Sun HW; Yu XJ; Wu WC; Chen J; Shi M; Zheng L; Xu J
    PLoS One; 2016; 11(12):e0168907. PubMed ID: 28036362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.
    Gao HJ; Zhao MC; Zhang YJ; Zhou DS; Xu L; Li GB; Chen MS; Liu J
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1151-62. PubMed ID: 25446815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.
    Meijer TW; Schuurbiers OC; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; Verhagen AF; Lok J; van der Heijden HF; Rademakers SE; Span PN; Bussink J
    Lung Cancer; 2012 Jun; 76(3):316-23. PubMed ID: 22153830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.
    Curry JM; Tuluc M; Whitaker-Menezes D; Ames JA; Anantharaman A; Butera A; Leiby B; Cognetti DM; Sotgia F; Lisanti MP; Martinez-Outschoorn UE
    Cell Cycle; 2013 May; 12(9):1371-84. PubMed ID: 23574725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of peritumoral heat-shock factor-1 in patients receiving resection of hepatocellular carcinoma.
    Zhang JB; Guo K; Sun HC; Zhu XD; Zhang B; Lin ZH; Zhang BH; Liu YK; Ren ZG; Fan J
    Br J Cancer; 2013 Sep; 109(6):1648-56. PubMed ID: 24002609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral reciprocal expression of monocarboxylate transporter 4 and glypican-3 in hepatocellular carcinomas.
    Yorita K; Ohno A; Nishida T; Kondo K; Ohtomo T; Kataoka H
    BMC Res Notes; 2019 Nov; 12(1):741. PubMed ID: 31706332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal-epithelial metabolic coupling in gastric cancer: stromal MCT4 and mitochondrial TOMM20 as poor prognostic factors.
    Zhao Z; Han F; He Y; Yang S; Hua L; Wu J; Zhan W
    Eur J Surg Oncol; 2014 Oct; 40(10):1361-8. PubMed ID: 24821064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
    Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
    Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
    Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High monocarboxylate transporter 4 protein expression in stromal cells predicts adverse survival in gastric cancer.
    Yan P; Li YH; Tang ZJ; Shu X; Liu X
    Asian Pac J Cancer Prev; 2014; 15(20):8923-9. PubMed ID: 25374230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
    Doyen J; Trastour C; Ettore F; Peyrottes I; Toussant N; Gal J; Ilc K; Roux D; Parks SK; Ferrero JM; Pouysségur J
    Biochem Biophys Res Commun; 2014 Aug; 451(1):54-61. PubMed ID: 25058459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
    Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
    J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of glioma-associated oncogene 2 (Gli 2) is correlated with poor prognosis in patients with hepatocellular carcinoma undergoing hepatectomy.
    Zhang D; Cao L; Li Y; Lu H; Yang X; Xue P
    World J Surg Oncol; 2013 Jan; 11():25. PubMed ID: 23356443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
    Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
    World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.
    Ambrosetti D; Dufies M; Dadone B; Durand M; Borchiellini D; Amiel J; Pouyssegur J; Rioux-Leclercq N; Pages G; Burel-Vandenbos F; Mazure NM
    PLoS One; 2018; 13(2):e0193477. PubMed ID: 29481555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma.
    Liu Y; Sun X; Huo C; Sun C; Zhu J
    Med Sci Monit; 2019 Jun; 25():4278-4284. PubMed ID: 31177263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis.
    Cao YW; Liu Y; Dong Z; Guo L; Kang EH; Wang YH; Zhang W; Niu HT
    Urol Oncol; 2018 Jun; 36(6):311.e15-311.e25. PubMed ID: 29657088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.